HYPRO Fundamental Analysis - HYDROGENPRO ASA

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to HYPRO. HYPRO was compared to 109 industry peers in the Machinery industry. HYPRO may be in some trouble as it scores bad on both profitability and health. HYPRO is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year HYPRO has reported negative net income.

In the past year HYPRO has reported a negative cash flow from operations.

In the past 5 years HYPRO always reported negative net income.

In the past 5 years HYPRO always reported negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -44.70%, HYPRO is doing worse than 94.50% of the companies in the same industry.

HYPRO has a worse Return On Equity (-77.95%) than 88.99% of its industry peers.

		Industry Rank	Sector Rank
ROA	-44.7%
ROE	-77.95%
ROIC	N/A

ROA(3y)-21.12%

ROA(5y)-15.37%

ROE(3y)-32.92%

ROE(5y)-22.58%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

HYPRO's Gross Margin of 45.93% is in line compared to the rest of the industry. HYPRO outperforms 59.63% of its industry peers.

HYPRO's Gross Margin has declined in the last couple of years.

HYPRO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	45.93%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-15.96%

GM growth 5Y-8.39%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

HYPRO does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, HYPRO has more shares outstanding

Compared to 5 years ago, HYPRO has more shares outstanding

Compared to 1 year ago, HYPRO has an improved debt to assets ratio.

2.2 Solvency

A Debt/Equity ratio of 0.04 indicates that HYPRO is not too dependend on debt financing.

With an excellent Debt to Equity ratio value of 0.04, HYPRO belongs to the best of the industry, outperforming 88.07% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.04
Debt/FCF	N/A
Altman-Z	N/A

ROIC/WACCN/A

WACC8.19%

2.3 Liquidity

HYPRO has a Current Ratio of 1.57. This is a normal value and indicates that HYPRO is financially healthy and should not expect problems in meeting its short term obligations.

HYPRO's Current ratio of 1.57 is in line compared to the rest of the industry. HYPRO outperforms 54.13% of its industry peers.

HYPRO has a Quick Ratio of 1.38. This is a normal value and indicates that HYPRO is financially healthy and should not expect problems in meeting its short term obligations.

HYPRO's Quick ratio of 1.38 is fine compared to the rest of the industry. HYPRO outperforms 77.98% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.57
Quick Ratio	1.38

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

HYPRO shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.78%.

The Revenue for HYPRO has decreased by -56.08% in the past year. This is quite bad

HYPRO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 50.72% yearly.

EPS 1Y (TTM)6.78%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%27.34%

Revenue 1Y (TTM)-56.08%

Revenue growth 3Y113.76%

Revenue growth 5Y50.72%

Sales Q2Q%-75.19%

3.2 Future

Based on estimates for the next years, HYPRO will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.19% on average per year.

Based on estimates for the next years, HYPRO will show a decrease in Revenue. The Revenue will decrease by -5.77% on average per year.

EPS Next Y7.69%

EPS Next 2Y17.62%

EPS Next 3Y16.19%

EPS Next 5YN/A

Revenue Next Year-81.22%

Revenue Next 2Y-34.28%

Revenue Next 3Y-5.77%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HYPRO. In the last year negative earnings were reported.

Also next year HYPRO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as HYPRO's earnings are expected to grow with 16.19% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y17.62%

EPS Next 3Y16.19%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

HYPRO does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

HYDROGENPRO ASA

OSL:HYPRO (1/6/2026, 11:12:08 AM)

2.395

+0.25 (+11.4%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryMachinery

Earnings (Last)11-14 2025-11-14

Earnings (Next)02-26 2026-02-26

Inst Owners5.51%

Inst Owner ChangeN/A

Ins Owners14.92%

Ins Owner ChangeN/A

Market Cap228.77M

Revenue(TTM)176.47M

Net Income(TTM)-213.32M

Analysts40

Price Target51 (2029.44%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	1.3
P/FCF	N/A
P/OCF	N/A
P/B	0.84
P/tB	1.03
EV/EBITDA	N/A

EPS(TTM)-2.89

EYN/A

EPS(NY)-1.78

Fwd EYN/A

FCF(TTM)-2.18

FCFYN/A

OCF(TTM)-1.67

OCFYN/A

SpS1.85

BVpS2.86

TBVpS2.33

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-44.7%
ROE	-77.95%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	45.93%
FCFM	N/A

ROA(3y)-21.12%

ROA(5y)-15.37%

ROE(3y)-32.92%

ROE(5y)-22.58%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-15.96%

GM growth 5Y-8.39%

F-Score3

Asset Turnover0.37

Health

		Industry Rank	Sector Rank
Debt/Equity	0.04
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	220.31%
Cap/Sales	27.49%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.57
Quick Ratio	1.38
Altman-Z	N/A

F-Score3

WACC8.19%

ROIC/WACCN/A

Cap/Depr(3y)100.78%

Cap/Depr(5y)485.48%

Cap/Sales(3y)14.13%

Cap/Sales(5y)41.52%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)6.78%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%27.34%

EPS Next Y7.69%

EPS Next 2Y17.62%

EPS Next 3Y16.19%

EPS Next 5YN/A

Revenue 1Y (TTM)-56.08%

Revenue growth 3Y113.76%

Revenue growth 5Y50.72%

Sales Q2Q%-75.19%

Revenue Next Year-81.22%

Revenue Next 2Y-34.28%

Revenue Next 3Y-5.77%

Revenue Next 5YN/A

EBIT growth 1Y-27.25%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year199.59%

EBIT Next 3Y35.52%

EBIT Next 5Y62.84%

FCF growth 1Y39.39%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y50.36%

OCF growth 3YN/A

OCF growth 5YN/A

HYDROGENPRO ASA / HYPRO.OL FAQ

What is the fundamental rating for HYPRO stock?

ChartMill assigns a fundamental rating of 2 / 10 to HYPRO.OL.

What is the valuation status for HYPRO stock?

ChartMill assigns a valuation rating of 0 / 10 to HYDROGENPRO ASA (HYPRO.OL). This can be considered as Overvalued.

How profitable is HYDROGENPRO ASA (HYPRO.OL) stock?

HYDROGENPRO ASA (HYPRO.OL) has a profitability rating of 0 / 10.

What is the financial health of HYDROGENPRO ASA (HYPRO.OL) stock?

The financial health rating of HYDROGENPRO ASA (HYPRO.OL) is 3 / 10.

HYDROGENPRO ASA (HYPRO.OL) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

HYDROGENPRO ASA / HYPRO.OL FAQ

What is the fundamental rating for HYPRO stock?

What is the valuation status for HYPRO stock?

How profitable is HYDROGENPRO ASA (HYPRO.OL) stock?

What is the financial health of HYDROGENPRO ASA (HYPRO.OL) stock?